USP36 and neoplasm: These findings suggest that targeting the PRL1/USP36/Snail2 axis could potentially inhibit epithelial–mesenchymal transition (EMT) and reduce tumor invasion and metastasis, making it an attractive target for future therapeutic interventions (Figure 2B).